Investment Team
Director
Antoine joined Astorg in 2018 and is a member of the Investment Team.
Prior to this, Antoine spent 3 years at Bain & Company in Paris including a long term assignment with the team dedicated to strategic due diligence for Private Equity funds.
Antoine graduated from Ecole des Mines de Paris.
CordenPharma
CordenPharma is a leading CDMO focused on fast-growing complex niche drug modalities with end to end capabilities from early stage development to commercial large-scale manufacturing.
Investment year: 2022
Sustainable development goals:
Clario
Clario delivers leading endpoint technology solutions for clinical trials.
Investment year: 2020
Sustainable development goals:
